No abstract available
Keywords:
CDK4/6; TK1; biomarker; breast cancer; endocrine therapy; luminal, prognosis; metastatic; resistance; thymidine kinase-1.
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Biomarkers, Tumor / metabolism*
-
Breast Neoplasms / diagnosis*
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / metabolism*
-
Clinical Trials as Topic
-
Drug Resistance, Neoplasm*
-
Humans
-
Thymidine Kinase / metabolism*
Substances
-
Biomarkers, Tumor
-
Thymidine Kinase